DavosPharma
Upper Saddle River, NJ, United States davos.com
From their website, Nov 2026
Work here? Claim this listing
- GLP
- GMP
About
DavosPharma coordinates drug development outsourcing for biotech and pharmaceutical companies, with support across discovery, CMC, toxicology, and regulatory strategy. It works with a global network of vetted CROs, CDMOs, and consultants to help clients reach IND submission.
Services
Integrated IND Platform
Manages a coordinated program from CMC and toxicology through regulatory strategy and vendor coordination for IND submission.
Discovery
Coordinates hit-to-lead chemistry, ADME/PK, early biology, in vitro and in vivo pharmacology, and bioanalytical method development through vetted CROs.
Assays & in vitro testing
Small Molecule
Matches projects involving peptides, HPAPIs, controlled substances, and complex chemistries with CDMOs for process development, scale-up, and manufacturing.
Biologics
Matches biologics programs with CDMOs for analytical development, potency testing, validation, and manufacturing of modalities such as antibodies, gene therapies, RNA-based platforms, vaccines, enzymes, and biosimilars.
Drug Product
Coordinates formulation development, preformulation assessment, tech transfer, validation support, and GMP manufacturing for drug products from capsules to injectables.
Toxicology
Coordinates GLP-compliant toxicology studies, including acute, subchronic, chronic, reproductive and DART, safety pharmacology, and genotoxicity work.
ADME, DMPK & toxicology
- Turnaround
- 3x faster average CRO onboarding time · 10-12 months average time from lab scale familiarization to delivery of Phase 1 API · 3x faster average CRO onboarding time compared to teams managing vendor outreach alone · 10-12 months our average time from lab scale familiarization to delivery of Phase 1 API
Capabilities
- Assays and studies
- Small molecules · Toxicology · Peptides · ADME · Antibodies · Fill-finish · Bioanalysis · In vivo · Analytical development · Hit-to-lead · ADME/PK · Early biology
17 more
In vitro pharmacology · In vivo pharmacology · Bioanalytical method development · Custom assay development · Potency testing · Analytical validation · Preformulation assessment · Acute toxicity · Subchronic toxicity · Chronic toxicity · Reproductive toxicity · Developmental toxicity (DART) · Hit-to-lead chemistry · Early biology studies · Developmental toxicity · Safety pharmacology · Genotoxicity - Scale and capacity
- Over 100 vetted CDMOs and CROs in the network · 80+ INDs filed to date
Modalities and species
- Modalities
- Small molecule · Antibody · Bispecific · ADC · Peptide · Oligonucleotide · mRNA · Viral vector · Cell therapy · Vaccine · Biosimilar
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
Scope: toxicology studies
GMPSelf-reported
Scope: drug product manufacturing and vetted manufacturing partners
Industries served
- Biotech
- Pharmaceutical
- Academic
- Industry
Company
- Type
- CRDMO
- Founded
- 1972
Locations
- Address
- 600 E Crescent Ave, Upper Saddle River, NJ 07458, United States
- Sites
- Upper Saddle River, United States
- Serves
- North America, Europe, Asia, global
Contacts
- Phone
- (201) 995-0070
Public records
- Biocom California CRO directory
- clinical trials, Custom Chemistry, Drug Product, Preclinical Research, process development source
Similar labs
Work here? Claim this listing